Mortality from cardiovascular disease is expected to rise exponentially over the next 20 years. Cardiovascular devices such as artificial hearts, lungs and valves are set to play an important role in managing these patients. Current and emerging devices follow a perilous development path prior to clinical implementation, whereby their subsequent uptake is often slow.
The purpose of the Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB) is to facilitate the transition of innovative cardiovascular technologies from idea to clinical implementation, whilst also investigating the clinical challenges facing existing technology.
That’s why our mission is to combat cardiovascular disease, and we do this by facilitating the integration of emerging cardiovascular devices and technology into clinical practice. Creating strong national and international collaborations is the key to developing innovative cardiac devices.